Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Scala

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Diagnostics (Basel, Switzerland)|June 10, 2023
Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis FungoidesCosimo Di Raimondo, Paolo Lombardo, Cristiano Tesei, et al.
Frontiers in Immunology|April 27, 2026
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseasesGiulia Salvatore, Ylenia Aura Minafò, Nicoletta Croce, et al.
The Journal of Investigative Dermatology|May 9, 2022
Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct PrognosisMario Picozza, Cristina Cristofoletti, Antonella Bresin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 27, 2023
Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort studyLorenzo Cecchi, Pascal Poncet, Lucia Maltagliati, et al.
Frontiers in Immunology|October 19, 2020
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With NivolumabMaria Grazia Narducci, Anna Tosi, Alessandra Frezzolini, et al.
Immunity, Inflammation and Disease|May 4, 2021
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literatureEnrico Scala, Luca Fania, Filippo Bernardini, et al.
Leukemia|December 7, 2018
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevanceCristina Cristofoletti, Antonella Bresin, Mario Picozza, et al.
Allergy|September 17, 2025
The Dual Face of Wheat and Cereal Reactivity: Molecular Divergence Between Soluble and Gluten-Derived AllergensEnrico Scala, Valeria Villella, Damiano Abeni, et al.
Cancer Research|September 2, 2008
CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokinesMaria Cristina Picchio, Enrico Scala, Debora Pomponi, et al.
The Journal of Allergy and Clinical Immunology|November 23, 2023
Phl p 5 levels more strongly associated than grass pollen counts with allergic respiratory healthElaine Fuertes, Debbie Jarvis, Holly Lam, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Diagnostics (Basel, Switzerland)|June 10, 2023
Role of Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Mycosis FungoidesCosimo Di Raimondo, Paolo Lombardo, Cristiano Tesei, et al.
Frontiers in Immunology|April 27, 2026
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseasesGiulia Salvatore, Ylenia Aura Minafò, Nicoletta Croce, et al.
The Journal of Investigative Dermatology|May 9, 2022
Genetically Driven CD39 Expression Affects Sezary Cell Viability and IL-2 Production and Detects Two Patient Subsets with Distinct PrognosisMario Picozza, Cristina Cristofoletti, Antonella Bresin, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 27, 2023
Optimization of the diagnosis and characterization of gibberellin-regulated protein sensitization: An Italian cohort studyLorenzo Cecchi, Pascal Poncet, Lucia Maltagliati, et al.
Frontiers in Immunology|October 19, 2020
Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With NivolumabMaria Grazia Narducci, Anna Tosi, Alessandra Frezzolini, et al.
Immunity, Inflammation and Disease|May 4, 2021
Pleomorphicskin eruptions in a COVID-19 affected patient: Case report and review of the literatureEnrico Scala, Luca Fania, Filippo Bernardini, et al.
Leukemia|December 7, 2018
Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K/AKT/mTORC1 pathway and its prognostic relevanceCristina Cristofoletti, Antonella Bresin, Mario Picozza, et al.
Allergy|September 17, 2025
The Dual Face of Wheat and Cereal Reactivity: Molecular Divergence Between Soluble and Gluten-Derived AllergensEnrico Scala, Valeria Villella, Damiano Abeni, et al.
Cancer Research|September 2, 2008
CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokinesMaria Cristina Picchio, Enrico Scala, Debora Pomponi, et al.
The Journal of Allergy and Clinical Immunology|November 23, 2023
Phl p 5 levels more strongly associated than grass pollen counts with allergic respiratory healthElaine Fuertes, Debbie Jarvis, Holly Lam, et al.
Pageof 8